Ipsen gains global rights to Foreseen Biotech’s FS001 ADC
Ipsen has entered an exclusive global licensing agreement with Foreseen Biotechnology for FS001, a potentially first-in-class antibody-drug conjugate (ADC). This…
Ipsen has entered an exclusive global licensing agreement with Foreseen Biotechnology for FS001, a potentially first-in-class antibody-drug conjugate (ADC). This…
Bayer and Asklepios BioPharmaceutical (AskBio) have announced US Food and Drug Administration (FDA) fast track designation for AB-1005, a gene…
Pan Cancer T, a US biotech firm specialising in next-generation T cell therapies for solid tumours, has announced the successful…
Tiba Biotech, a US preclinical biopharmaceutical company based in Cambridge, Massachusetts, has announced a partnership with the Biomedical Advanced Research…
Clinical-stage biopharmaceutical companies NextCure and LegoChem Biosciences have signed a collaboration and co-development agreement to develop a B7-H4 antibody drug…
Concept: Israel startup Inspekto has unveiled the second generation of its autonomous machine vision (AMV) system ‘INSPEKTO S70 Gen.2’ for…
Concept: US cybersecurity startup Elevate Security (Elevate) has launched an attack surface management platform that uses a customised and automated…
The Food and Drug Administration of the Philippines has approved Sputnik V Covid-19 vaccine for emergency use, as the country…
Tonix Pharmaceuticals has reported preliminary positive results after vaccinating monkeys with TNX-1800, a live modified horsepox virus vaccine for percutaneous…
Ampio Pharmaceuticals has revealed preliminary positive results of its AP-014 Phase I clinical trial that involves using of inhaled Ampion…